Merck global human health president
Executive Summary
GE Healthcare Bio-Sciences CEO Peter Loescher becomes Merck's first global human health president effective May 1. Loescher will oversee the company's sales and marketing divisions - U.S. Human Health, Human Health Asia Pacific, Human Health Intercontinental and Merck Vaccines - which previously reported directly to CEO Richard Clark. The global human health president position, created as part of the company's sales restructuring announced in December, is intended to produce greater continuity for customers across different markets (1"The Pink Sheet" Dec. 19, 2005, p. 3)...
You may also be interested in...
Merck Sales Restructuring Sacrifices Physician Detailing To Payer Marketing
Merck's restructuring program is shifting selling and marketing resources away from physician detailing towards payer and patient promotion, CEO Richard Clark indicated during the firm's annual business review in Whitehouse Station, N.J
New COVID Treatments Face FDA, Commercial Barriers Despite Ongoing Need
Sponsors want more endpoint clarity as current state of government pandemic response, along with scientific and regulatory hurdles, is constraining efforts to refill a shrinking COVID medicine cabinet and could create vulnerabilities for future pandemics.
China Planning To Ban Gene Editing Technology Exports
Beijing’s latest proposal to ban gene editing is viewed as a direct response to Washington’s tightening grip over the transfer of US technology to China.